Torrent Pharmaceuticals Ltd Share Price (TORNTPHARM)
as on
| Source : NSE
Torrent Pharmaceuticals Ltd Stock Performance
as on August 19, 2025 at 4:01 PM IST
Day's Low
Day's High
₹3,625₹3,663.8
0.73%
Downside
0.33%
Upside
52 Week's Low
52 Week's High
₹2,886.45₹3,787.920.95%
Downside
3.73%
Upside
| Market Stats | |
| Previous Close | ₹3,651.60 |
| Open | ₹3,660.80 |
| Volume | 1.97L |
| Upper Circuit | ₹4,016.70 |
| Lower Circuit | ₹3,286.50 |
| Day's Low | ₹3,625 |
| Day's High | ₹3,663.8 |
| 52 Week Low | ₹2,886.45 |
| 52 Week High | ₹3,787.9 |
| Returns % | |
| 1 Month Return | + 3.62 % |
| 3 Month Return | + 12.65 % |
| 1 Year Return | + 8.6 % |
| 3 Year Return | + 139.17 % |
| 5 Year Return | + 159.47 % |
Torrent Pharmaceuticals Ltd Stock Fundamentals & Key Indicators
Check Torrent Pharmaceuticals Ltd market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.
Market Cap
₹1,23,581.19 Cr
Return on Equity (ROE)
26.18
PE Ratio (TTM)
61.73
Return on capital employed (ROCE)
26.84
Industry PE ratio
43.53
Beta (LTM)
0.6
P/B Ratio
14.42
Dividend Yield
0.19
PEG Ratio
7.83
Quarterly Earnings Growth YOY
19.91
EPS (TTM)
56.47
Sector
Pharmaceuticals
Book Value
224.27
Technical Analysis
Bullish
View Technical Analysis
Torrent Pharmaceuticals Ltd Stock's Interest Amongst Investors
Torrent Pharmaceuticals Ltd Stock Valuation
Track how Torrent Pharmaceuticals Ltd P/E has moved over time to understand its valuation trends.
Torrent Pharmaceuticals Ltd in the last 5 years
Lowest (31.60x)
April 2, 2018
Industry (43.53x)
August 19, 2025
Today (61.73x)
August 19, 2025
Highest (73.85x)
April 3, 2019
Today’s Price to Earnings Ratio: 61.73x
Torrent Pharmaceuticals Ltd Stock Recommendation
Get updated buy, sell, and hold recommendations by analysts on Torrent Pharmaceuticals Ltd.
based on 26 analysts
73.08%
Buy
23.08%
Hold
3.85%
Sell
73.08% of analysts recommend a 'BUY' rating for Torrent Pharmaceuticals Ltd. Average target price of ₹3937.04
Source: S&P Global Market Intelligence
Torrent Pharmaceuticals Ltd Share Price Target
Get share price movements and forecasts by analysts on Torrent Pharmaceuticals Ltd.
Torrent Pharmaceuticals Ltd price forecast by 26 analysts
Upside of7.82%
High
₹4380
Target
₹3937.04
Low
₹3425
Torrent Pharmaceuticals Ltd target price ₹3937.04, a slight upside of 7.82% compared to current price of ₹3651.6. According to 26 analysts rating.
Excluding Excise Duty and Other Income, represents Net Revenue
Torrent Pharmaceuticals Ltd revenue growth forecast
Expected growth rate Q1, FY2027:26.82%
Forecast
Actual
Including amortisation and stock based compensations
Torrent Pharmaceuticals Ltd EPS growth forecast
EPS estimate Q1, FY2027:58.31%
Forecast
Actual
Source: S&P Global Market Intelligence
Torrent Pharmaceuticals Ltd Financial Results
Get the annual and quarterly financial summary of Torrent Pharmaceuticals Ltd, including revenue, profit, loss and more.
Torrent Pharmaceuticals Ltd Earnings and Dividends
View detailed summary of the earnings and dividend history of Torrent Pharmaceuticals Ltd.
Torrent Pharmaceuticals Ltd Earnings Results
Torrent Pharmaceuticals Ltd’s net profit jumped 19.91% since last year same period to ₹548.00Cr in the Q1 2025-2026. On a quarterly growth basis, Torrent Pharmaceuticals Ltd has generated 10.04% jump in its net profits since last 3-months.
Read More about Earnings ResultsTorrent Pharmaceuticals Ltd Dividends May,2025
In the quarter ending March 2025, Torrent Pharmaceuticals Ltd has declared dividend of ₹6.00 per share on 20 May 2025 - translating a dividend yield of 1.04%.
Read More about Dividends
Indices Featuring Torrent Pharmaceuticals Ltd Stock
Check stock indices that include Torrent Pharmaceuticals Ltd.
Torrent Pharmaceuticals Ltd Stock Shareholding Pattern
View the shareholding pattern breakup of promoters, FIIs, DIIs, and retail investors in Torrent Pharmaceuticals Ltd.
| Investors | Holdings % | Quarterly Trend | 3M change |
|---|---|---|---|
| Promoter Holdings | 68.31% | 0.00 | |
| Foreign Institutions | 16.09% | ||
| Mutual Funds | 4.95% | ||
| Retail Investors | 6.94% | ||
| Others | 3.71% | 11.44 |
Torrent Pharmaceuticals Ltd vs Peers
Compare market cap, revenue, PE, and other key metrics of Torrent Pharmaceuticals Ltd with its industry peers.
Company | Analyst View | Market Cap(in ₹ Cr) | 5 Year CAGR | Debt to Asset Ratio | Net Profit(in ₹ Cr) | Yearly Revenue(in ₹ Cr) |
|---|---|---|---|---|---|---|
| BUY | 1,23,581.19 | 31.89% | 0.66 | 1,911 | 11,516 | |
| HOLD | 1,61,391.62 | 18.12% | 0.50 | 2,191 | 9,360 | |
| BUY | 48,645.42 | -1.54% | 0.78 | 1,429 | 15,261 | |
| HOLD | 32,036.89 | 1.37% | 0.53 | 698 | 5,616 | |
| BUY | 1,25,113.03 | 20.62% | 0.51 | 5,291 | 27,547 |
Torrent Pharmaceuticals Ltd News & Key Events
Latest news and events in one place to help you make informed investing decisions in Torrent Pharmaceuticals Ltd.
Torrent Pharma's Vizag Facility Passes USFDA Inspection - 04 Aug, 2025
Torrent Pharmaceuticals' Vizag facility successfully cleared a USFDA inspection with zero observations. The company reported a 20% increase in net profit for Q1 FY25.Torrent Pharmaceuticals Reports Strong Q1 Results and Growth - 29 Jul, 2025
Torrent Pharmaceuticals reported an 11% YoY revenue growth and a 20% increase in net profit for Q1FY26. Analysts are optimistic, raising target prices and recommending accumulation. The company is also focusing on product launches in the US market to enhance recovery.Torrent Pharmaceuticals Reports Strong Q1 Growth and Future Plans - 28 Jul, 2025
Torrent Pharmaceuticals reported a 20% increase in net profit and 11% revenue growth for Q1 FY26. The company plans to launch generics of Novo Nordisk's drugs in Brazil next year.Torrent Pharma Hits Record High Amid Upgrades - 25 Jul, 2025
Torrent Pharmaceuticals saw a 3% rally, reaching a record high of ₹3,612.20. Investec upgraded the stock to buy, raising the target price to Rs 4,100, as the company awaits approval for a major acquisition of JB Chemicals & Pharmaceuticals.Torrent Pharma Seeks Major Acquisition Approval - 18 Jul, 2025
Torrent Pharmaceuticals is pursuing a ₹19,500 crore acquisition of J B Chemicals, pending CCI approval. The stock has gained for five consecutive sessions, reflecting strong performance.
Insights on Torrent Pharmaceuticals Ltd
Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.
POSITIVE IMPACTBest in 3 Years
In the last 3 years, TORNTPHARM has outperformed top 5 stocks with highest market-cap in Pharmaceuticals
- POSITIVE IMPACT
Revenue Rich
Revenue is up for the last 3 quarters, 2.84K Cr → 3.14K Cr (in ₹), with an average increase of 4.9% per quarter
- POSITIVE IMPACT
Price Rise
In the last 1 month, TORNTPHARM stock has moved up by 3.6%
- POSITIVE IMPACT
Profit Spike
Netprofit is up for the last 2 quarters, 498.0 Cr → 548.0 Cr (in ₹), with an average increase of 9.1% per quarter
NO EFFECTAgainst Peers
In the last 1 year, Divis Laboratories Ltd has given 32.0% return, outperforming this stock by 23.0%
- NO EFFECT
Promoter Holding Unchanged
Promoters holdings remained unchanged at 68.31% of holdings in Jun 2025 quarter
NEGATIVE IMPACTRetail Holding Down
Retail Investor have decreased holdings from 7.03% to 6.94% in Jun 2025 quarter
- NEGATIVE IMPACT
FII Holding Down
Foreign Institutions have decreased holdings from 16.31% to 16.09% in Jun 2025 quarter
- NEGATIVE IMPACT
MF Holding Down
Mutual Funds have decreased holdings from 5.03% to 4.95% in Jun 2025 quarter
About Torrent Pharmaceuticals Ltd
The company is focused on producing high-quality, affordable medicines for the treatment of a wide range of diseases. Its top products include cardiovascular drugs, antibiotics, anti-diabetic drugs, anti-inflammatory drugs, and anti-infective drugs. Popular brands include Cadila, Torleva, Torlip, and Torleva XR.
Revenue: ₹3,128.00Cr as on June 2025 (Q1 FY26)
Net Profit: ₹548.00Cr as on June 2025 (Q1 FY26)
Listing date: 03 Nov, 1994
Chairperson Name: Sudhir Mehta
| Organisation | Torrent Pharmaceuticals Ltd |
| Industry | Pharmaceuticals |
| CEO | Sudhir Mehta |
| E-voting on shares | Click here to vote |
Mutual Funds that own Torrent Pharmaceuticals Ltd Stock
Check out the Mutual Funds with significant holdings in Torrent Pharmaceuticals Ltd.
FAQs
What is Torrent Pharmaceuticals Ltd share price today?
Torrent Pharmaceuticals Ltd share price today stands at ₹3651.6, Open: ₹3660.8, Previous Close: ₹3651.6, High: ₹3663.8, Low: ₹3625, 52 Week High: ₹3787.9, 52 Week Low: ₹2886.45 as on .
How to buy Torrent Pharmaceuticals Ltd shares ?
To buy Torrent Pharmaceuticals Ltd shares, you need to follow these steps:
- Open a Demat account and Trading account on INDmoney
- Fund your Trading account
- Search for TORNTPHARM or Torrent Pharmaceuticals Ltd on the INDmoney app to check live prices of the stock
- Click on Buy or SIP to place an order to invest in Torrent Pharmaceuticals Ltd shares. You can invest by selecting the number of shares or set up a fixed SIP to invest every month or week.
What is today's traded volume of Torrent Pharmaceuticals Ltd?
Today's traded volume of Torrent Pharmaceuticals Ltd is 1.97L. Which means that 1.97L shares of Torrent Pharmaceuticals Ltd were bought and sold on the stock market during today's trading session.
What is Torrent Pharmaceuticals Ltd's market cap today?
Today's market capitalisation of Torrent Pharmaceuticals Ltd is ₹1,23,581.19 Cr. Market cap or market capitalisation is the total value of a company’s outstanding shares in the stock market, calculated by multiplying the current share price by the total number of shares issued by the company.
What is the 52 week high and 52 week low range of Torrent Pharmaceuticals Ltd?
Torrent Pharmaceuticals Ltd’s 52 week high is ₹3787.9 and 52 week low is ₹2886.45. The current share price of Torrent Pharmaceuticals Ltd is ₹3651.6, which is -3.60% down from its 52 week high and 26.51% up from its 52 week low.